Latest filing published 19 Feb 2021 for NexImmune, Inc..
No signal scores available.
Timothy Bertram is a declared insider at 2 companies; the most frequent names are Tengion Inc and NexImmune, Inc. Between 14 April 2010 and 17 February 2021, the trades on record add up to 8 filings.
The filings describe grants, exercises and other transfers rather than trades on the open market. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.
The latest filing, published on 19 February 2021, reports a transaction in NexImmune, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. For comparison, the SEC allows two business days to file a Form 4. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
8 of 8 declarations